Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Health insurance giant Aetna, which is owned by CVS Health, is launching fully insured and self-insured healthcare network options through Aetna Whole Health Atlanta.
A machine learning-powered smartphone application could help patients with a chronic cough document their symptoms over an extended period of time, according to new findings published in Digital Biomarkers.
An AI-powered wearable sensor can detect changes in heart failure patients before an actual crisis occurs, according to new findings published in Circulation: Heart Failure.
